Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Anti–PD-1/PD-L1 antibodies in non-small cell lung cancer: the era of immunotherapy
HTML
Details
Locations
Year:
2016
Type:
review
Source:
Expert Review of Anticancer Therapy
DOI:
10.1080/14737140.2017.1259574
Authors:
Gautam Kishore Valecha,
Adarsh Vennepureddy,
Uroosa Ibrahim,
Firas Safa,
Bachar Samra,
Jean Paul Atallah
show all 6
Institutions:
Staten Island University Hospital,
SUNY Downstate Health Sciences University
Language:
English
Topic:
Cancer Immunotherapy and Biomarkers
Subfield:
Oncology
Field:
Medicine
Domain:
Health Sciences
Keywords:
non-small cell lung cancer,
anti-PD-1,
PD-L1 inhibitors,
immune checkpoint inhibitors,
immunotherapy,
PD-1/PD-L1 pathway,
treatment response,
drug toxicity,
predictive biomarkers,
first-line therapy,
combination therapy
show all 11
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W2554978154
FWCI:
0.777
Cites:
67
Cited by:
46
Related to:
10